You are here: All Products  > SciClone Invests $3 Million in Soligenix; Finalizes China Oral Mucositis Drug In-licensing

SciClone Invests $3 Million in Soligenix; Finalizes China Oral Mucositis Drug In-licensing

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products